Incyte Genomics

Related by string. * InCyte : Incyte NASDAQ INCY . Incyte INCY . Incyte Corp . InCyte Chip Estimator . Incyte disclaims any . Incyte Corporation . Incyte Pharmaceuticals / GENOMICS . genomics . genomic : Synthetic Genomics . functional genomics proteomics . functional genomics . genomic sequencing . functional genomics proteomics bioinformatics . embrace genomic . Eureka Genomics * *

Related by context. Frequent words. (Click for all words.) 62 Bearish Pressure Building 62 PROFILE CO 61 quotes/comstock/# * 61 Rhone Poulenc Rorer 60 CEO Exercises Options 59 Lexicon Genetics 58 Calls Purchased 58 Q2 Profit Surges 57 Nasdaq BIIB 57 Director Exercises Options 57 Movers Roundup 56 Earnings Scorecard 56 Idera Pharmaceuticals 56 Discusses Q3 56 SWOT Analysis companiesandmarkets.com adds 56 Symyx Technologies 56 CEO Discusses Q1 55 Amersham Biosciences 55 Digene Corporation 55 Shares Changing Hands 55 Quintiles Transnational 55 Completes Tender Offer 55 Vicuron Pharmaceuticals 55 Q1 Loss Narrows 55 Explore Strategic Alternatives 55 Marvell Semiconductor 54 4Q Profit Jumps 54 Q4 Profit Surges 54 Lexicon Pharmaceuticals 54 Q2 Loss Narrows 54 Tandem Computers 54 Inotek 54 Stock Downgraded 54 CoMentis 54 #cv# [001] 54 Options Trader Alert 54 Q4 Loss Narrows 54 Lowers Guidance 53 Aerovance 53 Q3 Profit Surges 53 Stockholders Approve Merger 53 Q3 Loss Narrows 53 CFO Resigns 53 Nasdaq AMLN 53 Metabasis Therapeutics Inc. 53 Sirna Therapeutics 53 Q4 Loss Widens 53 ICOS Corporation 53 Dynavax Technologies 53 Esperion Therapeutics 53 Detects Unusual Activity 53 Q1 Loss Widens 53 Options Brief 53 Coley Pharmaceutical Group 53 TargeGen 53 Files Annual Report 52 Alnylam Pharmaceuticals 52 Sofinnova Ventures 52 Regeneron Pharmaceuticals 52 Q2 Loss Widens 52 Guides Below 52 Announces Definitive Agreement 52 NASDAQ CRXL 52 Applera Corp. 52 Merrimack Pharmaceuticals 52 Announces Organizational Changes 52 Rigel Pharmaceuticals 52 Q3 Loss Widens 52 Inc.and 52 Co. Initiates Independent 52 ALZA Corporation 52 Idenix Pharmaceuticals 52 2Q Profit Up 52 TheStreet Ratings rates 51 Ariad Pharmaceuticals 51 Bullish Pressure 51 Q2 Profit Declines 51 Syntex 51 Progenics Pharmaceuticals 51 Beats Analyst 51 Posts 4Q Loss 51 Closes Acquisition Of 51 EnVivo Pharmaceuticals 51 Monogram Biosciences 51 Named Cool Vendor 51 Webcast Annual Meeting 51 Q1 Profit Declines 51 Q1 Profit Rises 51 Hold Fourth Quarter 51 Finalizes Acquisition 51 Regulus Therapeutics 51 DJ DGAP DD 51 F#Q# Qtr End 51 Conference Call TRANSCRIPT 51 Sells Shares 51 SmarTrend Sell Recommendation 51 Genetech 51 Trubion Pharmaceuticals 51 Opko 51 BD Biosciences 51 Gilead Sciences NASDAQ GILD

Back to home page